Why is immunotherapy for glioblastoma "Lag"-ging

Dimitrios Mathios, Michael Lim

Research output: Contribution to journalEditorialpeer-review

Fingerprint

Dive into the research topics of 'Why is immunotherapy for glioblastoma "Lag"-ging'. Together they form a unique fingerprint.